Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial

• Main Authors: Francesco Di Pierro (Author), Amjad Khan (Author), Somia Iqtadar (Author), Sami Ullah Mumtaz (Author), Muhammad Nabeel Akbar Chaudhry (Author), Alexander Bertuccioli (Author), Giuseppe Derosa (Author), Pamela Maffioli (Author), Stefano Togni (Author), Antonella Riva (Author), Pietro Allegrini (Author), Martino Recchia (Author), Nicola Zerbinati (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Quercetin, a natural polyphenol with demonstrated broad-spectrum antiviral, anti-inflammatory, and antioxidant properties, has been proposed as an adjuvant for early-stage coronavirus disease 2019 (COVID-19) infection.Objective: To explore the possible therapeutic effect of quercetin in...